US 8114620
Diagnostic and therapeutic target PRKX proteins for neurodegenerative diseases
granted A61PA61P25/00A61P25/28
Quick answer
US patent 8114620 (Diagnostic and therapeutic target PRKX proteins for neurodegenerative diseases) held by Takeda Pharmaceutical Company Limited expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61P, A61P25/00, A61P25/28, A61P43/00